{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/d556eb54-6160-4c85-95f4-47d9f5216c49/6a9001f40c15e359f9cb103c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Big shot: does a cancer vaccine work? ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/62e286a934d4d93d6587424a/1787822275317-3631200e-ff6a-43d3-a12b-fa7448196b63.jpeg?height=200","description":"<p><a href=\"https://www.economist.com/science-and-technology/2026/08/21/it-now-seems-possible-to-vaccinate-against-cancer?utm_campaign=a.io&amp;utm_medium=audio.podcast.np&amp;utm_source=theintelligence&amp;utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&amp;utm_term=sa.listeners\" rel=\"noopener noreferrer\" target=\"_blank\">Personalised vaccines</a> could offer a breakthrough in the fight against cancer. Our correspondent analyses the latest trial. <a href=\"https://www.economist.com/business/2026/08/20/canadas-oil-industry-is-booming-can-it-last?utm_campaign=a.io&amp;utm_medium=audio.podcast.np&amp;utm_source=theintelligence&amp;utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&amp;utm_term=sa.listeners\" rel=\"noopener noreferrer\" target=\"_blank\">Canada’s oil </a>market is flourishing, despite the trade war. And, why we will always love <a href=\"https://www.economist.com/culture/2026/08/26/why-dolly-parton-mattered-to-america?utm_campaign=a.io&amp;utm_medium=audio.podcast.np&amp;utm_source=theintelligence&amp;utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&amp;utm_term=sa.listeners\" rel=\"noopener noreferrer\" target=\"_blank\">Dolly Parton</a>.</p><p><br></p><p>Guests and host:</p><ul><li>Natasha Loder, health editor</li><li>Sarah Lawrynuik, deputy editor of “The Intelligence”</li><li>Jon Fasman, senior culture correspondent</li><li>Jason Palmer, co-host of “The Intelligence”</li></ul><p><br></p><p>Topics covered:&nbsp;</p><ul><li>Cancer, immunotherapy, vaccines, mRNA</li><li>Oil, Canada, trade war, tariffs</li><li>Dolly Parton, country music</li></ul><p><br></p><p><em>Listen to what matters most, from global politics and business to science and technology—</em><a href=\"https://subscribenow.economist.com/podcasts-plus\" rel=\"noopener noreferrer\" target=\"_blank\"><em>subscribe to The Economist</em></a><em>.</em></p>","author_name":"The Economist"}